Flopristin/linopristin: Phase II started

Novexel began an investigator-blinded, North American Phase II trial to compare 500 mg of oral NXL103 given twice daily vs. 600 mg of oral Zyvox linezolid given twice daily for 10-14 days in 180 pati...